Concepedia

Yun-Wen Peng

YP

Statistics

Publications

5

Citations

206

H-Index

5

Active since

1998

Affiliations

Pfizer (United States)(Current)

University of Michigan

Yun-Wen Peng is an author at Pfizer (United States) specializing in pharmacology, protein phosphatase 2a regulation, and potency optimization.

Publications per year

1998–2020

5

Publications

5

Regulation of Protein Phosphatase 2A Activity by Caspase-3 during Apoptosis

Maxine Fico Santoro, R. R. Annand, Molly M. Robertson et al. · Journal of Biological Chemistry · 1998 · 152 citations · Full text

, , +15

The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis

Thomas B. McClanahan, Gary W. Hicks, Angela L Morrison et al. · European Journal of Pharmacology · 2001 · 17 citations

, , +11

Optimization of highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase

Noel A. Powell, Jennifer K. Hoffman, Fred L. Ciske et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 14 citations · Full text

, , +13

Normoxic re-oxygenation ameliorates end-organ injury after cardiopulmonary bypass

Yun-Wen Peng, Terry C. Major, Azmath Mohammed et al. · Journal of Cardiothoracic Surgery · 2020 · 13 citations · Full text

, , +14

Evaluation of an Anti-Thrombotic Continuous Lactate and Blood Pressure Monitoring Catheter in an In Vivo Piglet Model undergoing Open-Heart Surgery with Cardiopulmonary Bypass

Kenneth K. Y. Ho, Yun-Wen Peng, Minyi Ye et al. · Chemosensors · 2020 · 10 citations · Full text

, , +15

1–5 of 5